chr9-116687354-T-C

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_012210.4(TRIM32):​c.-109T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000428 in 738,136 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., cov: 25)
Exomes 𝑓: 0.00045 ( 1 hom. )

Consequence

TRIM32
NM_012210.4 5_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 0.161

Publications

0 publications found
Variant links:
Genes affected
TRIM32 (HGNC:16380): (tripartite motif containing 32) The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. The protein has also been localized to the nucleus, where it interacts with the activation domain of the HIV-1 Tat protein. The Tat protein activates transcription of HIV-1 genes. [provided by RefSeq, Jul 2008]
ASTN2 (HGNC:17021): (astrotactin 2) This gene encodes a protein that is expressed in the brain and may function in neuronal migration, based on functional studies of the related astrotactin 1 gene in human and mouse. A deletion at this locus has been associated with schizophrenia. Multiple transcript variants encoding different proteins have been found for this locus. [provided by RefSeq, May 2010]
ASTN2 Gene-Disease associations (from GenCC):
  • autism spectrum disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIM32NM_012210.4 linkc.-109T>C 5_prime_UTR_variant Exon 1 of 2 ENST00000450136.2 NP_036342.2 Q13049A0A024R843
ASTN2NM_001365068.1 linkc.2807-35561A>G intron_variant Intron 16 of 22 ENST00000313400.9 NP_001351997.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIM32ENST00000450136.2 linkc.-109T>C 5_prime_UTR_variant Exon 1 of 2 1 NM_012210.4 ENSP00000408292.1 Q13049
ASTN2ENST00000313400.9 linkc.2807-35561A>G intron_variant Intron 16 of 22 5 NM_001365068.1 ENSP00000314038.4 O75129-1

Frequencies

GnomAD3 genomes
AF:
0.000336
AC:
46
AN:
136716
Hom.:
0
Cov.:
25
show subpopulations
Gnomad AFR
AF:
0.000111
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000721
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000245
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000593
Gnomad OTH
AF:
0.000520
GnomAD4 exome
AF:
0.000449
AC:
270
AN:
601330
Hom.:
1
Cov.:
8
AF XY:
0.000434
AC XY:
122
AN XY:
280892
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
11074
American (AMR)
AF:
0.00
AC:
0
AN:
866
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3662
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2560
South Asian (SAS)
AF:
0.00
AC:
0
AN:
11842
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
214
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1220
European-Non Finnish (NFE)
AF:
0.000485
AC:
267
AN:
550304
Other (OTH)
AF:
0.000153
AC:
3
AN:
19588
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000336
AC:
46
AN:
136806
Hom.:
0
Cov.:
25
AF XY:
0.000287
AC XY:
19
AN XY:
66294
show subpopulations
African (AFR)
AF:
0.000111
AC:
4
AN:
36056
American (AMR)
AF:
0.0000720
AC:
1
AN:
13886
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3336
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4252
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3914
European-Finnish (FIN)
AF:
0.000245
AC:
2
AN:
8178
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
278
European-Non Finnish (NFE)
AF:
0.000593
AC:
38
AN:
64118
Other (OTH)
AF:
0.000515
AC:
1
AN:
1942
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000864
Hom.:
0
Bravo
AF:
0.000227

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Sarcotubular myopathy Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Bardet-Biedl syndrome 11 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
17
DANN
Benign
0.57
PhyloP100
0.16
PromoterAI
0.039
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs886063378; hg19: chr9-119449633; API